Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on May 20, 2025
LeddarTech fait le point sur sa situation financière et annonce une réduction de ses effectifs
GlobeNewswire
·
May 20, 2025
QUÉBEC, Canada, 20 mai 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (« LeddarTech » ou la « Société ») (NASDAQ : LDTC), une société de logiciels alimentés par l’IA et reconnue pour son innovation dans les systèmes avancés d’aide à la conduite ( …
LeddarTech Provides Update on Financial Situation and Announces Workforce Reduction
GlobeNewswire
·
May 20, 2025
QUEBEC CITY, Canada, May 20, 2025 (GLOBE NEWSWIRE) -- LeddarTech® Holdings Inc. (“LeddarTech” or the “Company”) (Nasdaq: LDTC), an AI-powered software company recognized for its innovation in advanced driver assistance systems (ADAS) and autonomous driving …
Online Marketing for Doctors Delivers Exceptional Growth Results for Medical Professionals
GlobeNewswire
·
May 20, 2025
Online Marketing for Doctors empowers healthcare professionals worldwide to achieve rapid, measurable growth through specialized digital strategies. Their clients report major boosts in website traffic, patient inquiries, and marketing efficiency, while …
Nearfield Instruments and Singapore’s A*STAR IME Sign Research Collaboration Agreement to Advance Semiconductor Metrology Solutions for AI and Advanced Packaging Era
GlobeNewswire
·
May 20, 2025
SINGAPORE, May 20, 2025 (GLOBE NEWSWIRE) -- Nearfield Instruments, a leader in advanced semiconductor metrology, and the A*STAR Institute of Microelectronics (A*STAR IME) of Singapore, today have signed a multi-year research collaboration agreement to …
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
GlobeNewswire
·
May 20, 2025
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully upsized its offering and priced approximately $2,300,000,000 (equivalent) of its senior notes (the “ …
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 20, 2025
SOUTH SAN FRANCISCO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the Company’s new Chief …
Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth
GlobeNewswire
·
May 20, 2025
VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) -- Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly announces its strategic amalgamation with Klonetics Plant Science Inc., a licensed cannabis nursery and …
XRP News: Vaultro Finance Presale Gains Investor Attention as It’s Index Fund Protocol Interface Goes Live!
GlobeNewswire
·
May 20, 2025
SINGAPORE, May 20, 2025 (GLOBE NEWSWIRE) -- The excitement around the XRP Ledger continues to grow and Vaultro Finance is riding the wave with full force. As XRP maintains strong trading momentum above the two dollar fifty mark, the first decentralized …
TrialWire the AI and Algorithm-powered Platform Named a Fierce CRO Award Finalist in the “Outstanding Patient Recruitment and Retention” Category
GlobeNewswire
·
May 20, 2025
SAN FRANCISCO, May 20, 2025 (GLOBE NEWSWIRE) -- TrialWire today announces it was named a Fierce CRO Award finalist by Fierce Biotech in the Outstanding Patient Recruitment and Retention category. TrialWire is the AI and algorithm-powered patient- …
Fitch Ratings Agency Upgrades Teva Rating to BB+ Recognizing Successful Execution of Its Pivot to Growth Strategy
GlobeNewswire
·
May 20, 2025
TEL AVIV, Israel, May 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE and TASE: TEVA) today announced that Fitch Ratings Agency (“Fitch”) has raised the Company's corporate credit rating to BB+, with a stable outlook; from BB. Fitch's report cites …
Neuphoria Provides First Quarter 2025 Business Updates
GlobeNewswire
·
May 20, 2025
Cash runway into Q3 2026 AFFIRM-1 Phase 3 clinical trial of BNC-210 in social anxiety disorder on track for topline readout in Q3 2025 α7 nicotinic acetylcholine receptor PAM MK-1167 partnered with Merck and in Phase 2 clinical trial in Alzheimer’s …
ESCO Announces Divestiture of VACCO Industries
GlobeNewswire
·
May 20, 2025
St. Louis, May 20, 2025 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today announced that it has entered into a definitive agreement to sell VACCO Industries (VACCO) to RBC Bearings Incorporated (NYSE: RBC), an …
GENFIT va recevoir un paiement d’étape de 26,5 millions d’euros à la suite de l’approbation du prix et du remboursement d’Iqirvo® par Ipsen en Italie
GlobeNewswire
·
May 20, 2025
Lille (France), Cambridge (Massachusetts, Etats-Unis), Zurich (Suisse), le 20 mai, 2025 – GENFIT (Nasdaq et Euronext : GNFT), société́ biopharmaceutique de stade clinique avancé engagée dans l’amélioration de la vie des patients atteints de maladies rares …
GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen’s Iqirvo® in Italy
GlobeNewswire
·
May 20, 2025
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today …
Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with…
GlobeNewswire
·
May 20, 2025
REDWOOD CITY, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced data presented from its clinical development …
INVO Fertility Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 20, 2025
SARASOTA, Fla., May 20, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Tactile Medical to Present at Upcoming Investor Conferences in June
GlobeNewswire
·
May 20, 2025
MINNEAPOLIS, May 20, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will be …
Prairie Band Casino & Resort Transitions from Viz Explorer to Quick Custom Intelligence’s (QCI) Enterprise Platform
GlobeNewswire
·
May 20, 2025
SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), a leader in advanced casino management solutions, is excited to announce that Prairie Band Casino has chosen the QCI Enterprise Platform to enhance its data-driven operations. …
Avalyn Showcases Clinical Data Across Multiple Pulmonary Fibrosis Programs at ATS 2025
GlobeNewswire
·
May 20, 2025
Topline results for AP02 (inhaled nintedanib) confirmed safety and tolerability with limited systemic exposure and substantially improved lung exposure compared to oral nintedanib AP01 (inhaled pirfenidone) treatment demonstrated long-term antifibrotic …
HonorHealth Research Institute patient with advanced skin cancer in remission for more than a year following clinical trial of Werewolf Therapeutics' investigational novel conditionally activated IL-2 pro-drug WTX-124
GlobeNewswire
·
May 20, 2025
There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening Skin Cancer Awareness Month in May shines a spotlight on the growing burden of advanced skin cancers …